Patients who took Eli Lilly's weight loss drug Zepbound regained around half the weight they lost after stopping the newly approved treatment for a year, according to new data.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
